EMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions ATLANTA, GA - July 29, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.
ATLANTA, GA - July 29, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing multi-antigenic vaccines and immunotherapies against infectious diseases and cancer, ...
ATLANTA, GA - September 22, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines, today reaffirmed its commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results